Anika Therapeutics Terminates Contract With U.S. Distribution Partner for ELEVESS

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (“HA”) technology, has terminated its U.S. distribution contract with Artes Medical for ELEVESS®, its injectable dermal filler that reduces the appearance of lines and wrinkles on the face. This follows Artes Medical’s disclosure that it has initiated a significant workforce reduction, and that it has not been able to address its anticipated liquidity issues. Anika values the customers for the product and will continue efforts on its own to service these customers while actively seeking a new partner for the U.S. distribution of ELEVESS, which was the first HA-based dermal filler approved by the U.S. Food and Drug Administration to incorporate the anesthetic lidocaine to improve patient comfort.